161 related articles for article (PubMed ID: 6158066)
21. Modification of rat brain 5-hydroxytryptamine metabolism by sublethal doses of organophosphate agents.
Prioux-Guyonneau M; Coudray-Lucas C; Coq HM; Cohen Y; Wepierre J
Acta Pharmacol Toxicol (Copenh); 1982 Oct; 51(4):278-84. PubMed ID: 6184944
[TBL] [Abstract][Full Text] [Related]
22. The effects of acute and extended monoamine oxidase inhibition upon 5-hydroxyindoles in maturing mouse brain.
Baker PC; Hoff KM
Gen Pharmacol; 1991; 22(2):347-52. PubMed ID: 1711492
[TBL] [Abstract][Full Text] [Related]
23. Effects of idebenone on metabolism of monoamines and cyclic AMP formation in rats.
Nagai Y; Narumi S; Kakihana M; Yamazaki N; Nagaoka A; Nagawa Y
Arch Gerontol Geriatr; 1989 May; 8(3):273-89. PubMed ID: 2475075
[TBL] [Abstract][Full Text] [Related]
24. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
Green AR; DeSouza RJ; Davies EM; Cross AJ
Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944
[TBL] [Abstract][Full Text] [Related]
25. L-5-hydroxytryptophan. Correlation between anticonvulsant effect and increases in levels of 5-hydroxyindoles in plasma and brain.
Löscher W; Pagliusi SR; Müller F
Neuropharmacology; 1984 Sep; 23(9):1041-8. PubMed ID: 6083501
[TBL] [Abstract][Full Text] [Related]
26. The failure of p-chlorophenylalanine to affect voluntary alcohol consumption in rats.
Holman RB; Hoyland V; Shillito EE
Br J Pharmacol; 1975 Feb; 53(2):299-304. PubMed ID: 125129
[TBL] [Abstract][Full Text] [Related]
27. Action of harman (1-methyl-beta-carboline) on the brain: body temperature and in vivo efflux of 5-HT from hippocampus of the rat.
Adell A; Biggs TA; Myers RD
Neuropharmacology; 1996; 35(8):1101-7. PubMed ID: 9121613
[TBL] [Abstract][Full Text] [Related]
28. Changes in mouse brain serotonin turnover following chronic imipramine administration.
Hall TR; Urueña G; Figueroa HR
Gen Pharmacol; 1985; 16(1):55-9. PubMed ID: 2579874
[TBL] [Abstract][Full Text] [Related]
29. Prostaglandin E1 causes sedation and increases 5-hydroxytryptamine turnover in rat brain.
Haubrich DR; Perez-Cruet J; Reid WD
Br J Pharmacol; 1973 May; 48(1):80-7. PubMed ID: 4269288
[TBL] [Abstract][Full Text] [Related]
30. Effect of p-chlorophenylalanine on diazepam withdrawal signs in rats.
Suzuki T; Fukumori R; Yoshii T; Yanaura S; Satoh T; Kitagawa H
Psychopharmacology (Berl); 1980; 71(1):91-3. PubMed ID: 6161385
[TBL] [Abstract][Full Text] [Related]
31. Early postnatal inhibition of serotonin synthesis results in long-term reductions of perseverative behaviors, but not aggression, in MAO A-deficient mice.
Bortolato M; Godar SC; Tambaro S; Li FG; Devoto P; Coba MP; Chen K; Shih JC
Neuropharmacology; 2013 Dec; 75():223-32. PubMed ID: 23871843
[TBL] [Abstract][Full Text] [Related]
32. Effect of the antiepileptic di-n-propylacetamide on 5-hydroxytryptamine turnover in the brain and 5-hydroxyindoleacetic acid level in the cerebrospinal fluid.
Whitton PS; Oresković D; Marković Z; Skarpa D; Bulat M
Eur J Pharmacol; 1983 Jul; 91(1):57-62. PubMed ID: 6193970
[TBL] [Abstract][Full Text] [Related]
33. The effects of the anticonvulsant valproic acid on cerebral indole amine metabolism.
MacMillan V
Can J Physiol Pharmacol; 1979 Aug; 57(8):843-7. PubMed ID: 387187
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of the effects of selank and tuftsin on the metabolism of serotonin in the brain of rats pretreated with PCPA].
Semenova TP; kozlovskiĭ II; Zakharova NM; Kozlovskaia MM
Eksp Klin Farmakol; 2009; 72(4):6-8. PubMed ID: 19803361
[TBL] [Abstract][Full Text] [Related]
35. Indoleacetic acid-induced hypothermia and changes in serotonin metabolism in mice.
Yamada J; Sugimoto Y; Horisaka K
J Pharmacobiodyn; 1985 Jul; 8(7):564-70. PubMed ID: 2415696
[TBL] [Abstract][Full Text] [Related]
36. [3H]paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment.
Dewar KM; Grondin L; Carli M; Lima L; Reader TA
J Neurochem; 1992 Jan; 58(1):250-7. PubMed ID: 1370077
[TBL] [Abstract][Full Text] [Related]
37. [Action mechanism of anticonvulsant and anti-immobility (forced swim) effects of 3', 4'-dihydro-N, N-dimethylspiro-[9H-fluorene-9, 2' (5'H) furane]-3'-methanamine (AE37F)].
Vamvakidès A; Antoniou K; Daïfoti Z
Ann Pharm Fr; 2004 Jan; 62(1):49-55. PubMed ID: 14747773
[TBL] [Abstract][Full Text] [Related]
38. Role of serotoninergic and adrenergic mechanisms in the action of prominal.
Nowakowska E; Godlewski J
Acta Physiol Pol; 1979; 30(5-6):581-7. PubMed ID: 93847
[TBL] [Abstract][Full Text] [Related]
39. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
Hewton R; Salem A; Irvine RJ
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
[TBL] [Abstract][Full Text] [Related]
40. Quipazine: its effects on rat brain 5-hydroxytryptamine metabolism, monoamine oxidase activity and behaviour.
Green AR; Youdim MB; Grahame-Smith DG
Neuropharmacology; 1976 Mar; 15(3):173-9. PubMed ID: 132619
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
